<DOC>
	<DOCNO>NCT01629394</DOCNO>
	<brief_summary>Postoperative residual curarization post anaesthesia unit associate complication involve respiratory function impair laryngeal pharyngeal muscle ' function . Speed reversal neuromuscular blockade administration sugammadex versus neostigmine study , date data available concern continuous acceleromyography monitoring adductor pollicis corrugator supercilii morbidly obese patient undergo weight loss surgery . The investigator ' aim prospective , double-blinded study compare train four ( TOF ) value , presence absence clinical criterion postoperative residual curarization , dose requirement side effect sugammadex neostigmine reversal rocuronium induce neuromuscular blockade patient undergo laparoscopic open surgery morbid obesity .</brief_summary>
	<brief_title>Comparative Study Sugammadex Versus Neostigmine Reversal Neuromuscular Blockade Morbidly Obese Patients</brief_title>
	<detailed_description>Morbidly obese patient [ body mass index ( BMI ) &gt; 40 kg/m2 ] plan undergo open laparoscopic surgery weight loss manage standardized general anesthesia ( intravenous Propofol combine remifentanil muscle relaxation induce rocuronium ) . By end surgery , Group A group E patient receive sugammadex 2 mg/kg correct body weight [ correct body weight ( CBW ) =ideal body weight ( IBW ) + 40 % ( real body weight ( RBW ) -ideal body weight ) ] T2 arises adductor pollicis . Group C group G receive neostigmine 50μg/kg correct body weight T2 arises adductor pollicis . Group B group F patient receive sugammadex 2 mg/kg ideal body weight T2 arises adductor pollicis . Group D group H patient receive 50μg/kg neostigmine ideal body weight . Investigators proceed continuous acceleromyography monitoring adductor pollicis corrugator supercilii induction anaesthesia , surgery , recovery post anaesthesia care unit , record TOF value . Total consumption neuromuscular block agent , dose reversal agent clinical criterion post operation residual curarization also record .</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<mesh_term>Neostigmine</mesh_term>
	<criteria>Body mass index ( BMI ) &gt; 40kg Age &lt; 60 Patients write consent participate study Cardiovascular disease ( NYHA &gt; 2 ) Patients refusal participate study Contraindication epidural catheter placement ( e.g anticoagulation , anti platelet medication ) coexist neuromuscular disease history allergic reaction neuromuscular block agent history difficult intubation creatinine level &gt; 159lmol/l</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>